“Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s,” by Jonathan D. Rockoff, Wall Street Journal

“Pfizer Inc. PFE 0.19% said Saturday it will stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders. . . . Like several peers, Pfizer has invested heavily in developing treatments for Alzheimer’s and Parkinson’s because of the huge need, but met disappointment when once-promising compounds failed to work during testing.”

LTC Comment (from Stephen A. Moses, President, Center for Long-Term Care Reform):

More bad news on Alzheimer’s research.

Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s

#pfizer
#goldencareagent